New Product Launch Phillips-Medisize recently launched a needle-free, wearable continuous glucose monitoring system in partnership with GlucoModicum, promising enhanced convenience and accuracy. This innovative product represents a significant sales opportunity in the diabetes care market.

International Expansion With expansions in France and Poland, including purpose-built facilities, Phillips-Medisize has extended its reach in the EU. These new locations provide sales professionals with the opportunity to tap into emerging markets and broaden the company's customer base.

Collaborative Development The collaboration between Phillips-Medisize and GlucoModicum to develop non-invasive wearable devices for continuous glucose monitoring presents a strategic sales avenue. This partnership showcases the company's commitment to cutting-edge solutions, offering sales teams a compelling value proposition for prospective clients.

Award Recognition Phillips-Medisize received the prestigious Regents Business Partnership Award from the Universities of Wisconsin and UW-Stout. This recognition highlights the company's excellence in innovation and collaboration, which can be leveraged by sales professionals to build credibility and attract new business partnerships.

Market Expansion Opportunity As a key player in medical equipment manufacturing with a strong focus on quality and risk management, Phillips-Medisize's revenue exceeding $1 billion signifies a robust financial standing. This financial stability can be utilized by sales teams to position the company as a reliable and capable partner for long-term business relationships.